lunes, 26 de mayo de 2014

The population impact of familial cancer, a maj... [Int J Cancer. 2014] - PubMed - NCBI

The population impact of familial cancer, a maj... [Int J Cancer. 2014] - PubMed - NCBI

 2014 Apr 15;134(8):1899-906. doi: 10.1002/ijc.28510. Epub 2013 Oct 31.

The population impact of familial cancer, a major cause of cancer.


The population attributable fraction (PAF) defines the proportion of a disease that would be prevented if the exposure to a particular risk factor was avoided. Familial risk is a known risk factor for many cancers, but an unbiased estimation of the PAF for familial risk requires a large study population to include rare cancers. PAFs and their corresponding standardized incidence ratios (SIRs) were calculated for familial relative risk among first-degree relatives (FDRs) and second-degree relatives (SDRs) diagnosed with the same (concordant) invasive or in situ cancers. Calculations were based on the Swedish Family-Cancer Database considering 8,148,737 individuals. To assess environmental effects, PAFs were also calculated for concordant cancers among spouses. Almost all cancers showed a significant familial risk. The highest PAFs were found for the common cancers of the prostate (13.94%), breast (7.46%) and colorectum (6.78%) among the FDRs. In the FDRs, the overall PAF for any concordant cancer was 4.20%, but in the SDRs, it was only 0.34%. The overall PAFs for in situ cancers were 0.86% and 0.56% for the FDRs and SDRs, respectively. The overall independent familial PAF was 5.96% for the invasive and in situ cancers in the FDRs and SDRs. The cancers between spouses yielded an overall PAF of 0.14%. For esophageal cancer, the risk among spouses was higher than the familial risk. Our study shows that the overall familial PAF of 5.96%, although underestimated for sex-specific cancers, ranks as the third most common population burden after tobacco smoking and unhealthy diet.
© 2013 UICC.


Sweden, familial risk, population attributable fraction, spouse risk, standardized incidence ratio

[PubMed - indexed for MEDLINE]

No hay comentarios:

Publicar un comentario